AR228865A1 - Procedimientos para aislar antigenos glicoproteicos de virus,del tipo myxovirus,paramyxovirus,rhabdovirus y virus de leucosas,que presentan una membrana lipidica que contiene glicoproteinas - Google Patents

Procedimientos para aislar antigenos glicoproteicos de virus,del tipo myxovirus,paramyxovirus,rhabdovirus y virus de leucosas,que presentan una membrana lipidica que contiene glicoproteinas

Info

Publication number
AR228865A1
AR228865A1 AR285278A AR28527881A AR228865A1 AR 228865 A1 AR228865 A1 AR 228865A1 AR 285278 A AR285278 A AR 285278A AR 28527881 A AR28527881 A AR 28527881A AR 228865 A1 AR228865 A1 AR 228865A1
Authority
AR
Argentina
Prior art keywords
viruses
leukoses
myxovirus
rhabdovirus
paramyxovirus
Prior art date
Application number
AR285278A
Other languages
English (en)
Spanish (es)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of AR228865A1 publication Critical patent/AR228865A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AR285278A 1980-06-05 1981-05-11 Procedimientos para aislar antigenos glicoproteicos de virus,del tipo myxovirus,paramyxovirus,rhabdovirus y virus de leucosas,que presentan una membrana lipidica que contiene glicoproteinas AR228865A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8012522A FR2483779A1 (fr) 1980-06-05 1980-06-05 Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins

Publications (1)

Publication Number Publication Date
AR228865A1 true AR228865A1 (es) 1983-04-29

Family

ID=9242745

Family Applications (1)

Application Number Title Priority Date Filing Date
AR285278A AR228865A1 (es) 1980-06-05 1981-05-11 Procedimientos para aislar antigenos glicoproteicos de virus,del tipo myxovirus,paramyxovirus,rhabdovirus y virus de leucosas,que presentan una membrana lipidica que contiene glicoproteinas

Country Status (19)

Country Link
US (1) US4344935A (en:Method)
EP (1) EP0041880B1 (en:Method)
JP (1) JPS5726624A (en:Method)
AR (1) AR228865A1 (en:Method)
AT (1) ATE3239T1 (en:Method)
AU (1) AU546088B2 (en:Method)
CA (1) CA1174598A (en:Method)
DE (1) DE3160264D1 (en:Method)
DK (1) DK228081A (en:Method)
ES (1) ES8203225A1 (en:Method)
FI (1) FI811685A7 (en:Method)
FR (1) FR2483779A1 (en:Method)
GR (1) GR74610B (en:Method)
IE (1) IE51226B1 (en:Method)
IL (1) IL62913A (en:Method)
NO (1) NO811873L (en:Method)
NZ (1) NZ197306A (en:Method)
PT (1) PT73032B (en:Method)
ZA (1) ZA813479B (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721675A (en) * 1982-02-01 1988-01-26 Abbott Laboratories Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system
US4645666A (en) * 1982-06-08 1987-02-24 The Regents Of The University Of California Vaccine for bluetongue disease employing platinum compounds
GB8502096D0 (en) * 1985-01-28 1985-02-27 Medical Res Council Influenza vaccine
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US4909940A (en) * 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
US4975119A (en) * 1989-04-25 1990-12-04 Rheox, Inc. Liquid antisettling agents for organic coating compositions
FR2671974A1 (fr) * 1991-01-24 1992-07-31 Pasteur Merieux Serums Vacc Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.
US5741493A (en) * 1991-01-24 1998-04-21 Pasteur Merieux Serums Et Vaccins Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive
US6780630B1 (en) * 1992-07-10 2004-08-24 Baylor College Of Medicine Parenteral immunization against rotavirus
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
JPH11507831A (ja) 1995-06-14 1999-07-13 ベイラー・カレッジ・オブ・メディスン ロタウイルスエンテロトキシンｎｓｐ４およびそれを用いる方法
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE661402A (en:Method) 1964-03-20
US3847737A (en) * 1965-03-22 1974-11-12 A Kanarek Inactivation of myxoviruses and method of preparing a vaccine therefrom
US3629470A (en) * 1968-04-08 1971-12-21 Burroughs Wellcome Co Process for purification of animal rna viruses
BR6915288D0 (pt) * 1969-03-15 1973-02-08 Bayer Ag Processo para a purificacao de solucoes do virus da febre aftosa
US3989818A (en) * 1970-08-14 1976-11-02 South African Inventions Development Corporation Influenza virus vaccine
US3790552A (en) * 1972-03-16 1974-02-05 Us Health Method of removing hepatitis-associated antigen from a protein fraction using polyethylene glycol
US3962421A (en) * 1973-06-18 1976-06-08 American Home Products Corporation Method for the disruption of lipid-containing viruses
GB1486557A (en) 1973-10-18 1977-09-21 Flockhart & Co Process for the preparation of pyrogen-free sub-unit vaccine
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
US4064232A (en) * 1974-01-14 1977-12-20 Sandoz Ltd. Process for isolating the immunogenic components of influenza viruses
AU507149B2 (en) 1975-01-16 1980-02-07 Mount Sinai School Of Medicine Of The City University Of New York, The Method of influenza immunization
FR2422720A2 (fr) 1977-04-26 1979-11-09 Elf Aquitaine Separation et purification de proteines par chromatographie
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen

Also Published As

Publication number Publication date
PT73032A (fr) 1981-06-01
JPS5726624A (en) 1982-02-12
CA1174598A (en) 1984-09-18
IL62913A (en) 1984-08-31
DE3160264D1 (en) 1983-06-16
PT73032B (fr) 1982-07-01
IE51226B1 (en) 1986-11-12
GR74610B (en:Method) 1984-06-29
FR2483779A1 (fr) 1981-12-11
FR2483779B1 (en:Method) 1983-07-22
NZ197306A (en) 1984-03-16
ES502549A0 (es) 1982-04-01
US4344935A (en) 1982-08-17
ES8203225A1 (es) 1982-04-01
FI811685L (fi) 1981-12-06
AU546088B2 (en) 1985-08-15
NO811873L (no) 1981-12-07
IL62913A0 (en) 1981-07-31
EP0041880B1 (fr) 1983-05-11
ATE3239T1 (de) 1983-05-15
EP0041880A1 (fr) 1981-12-16
AU7117081A (en) 1981-12-10
ZA813479B (en) 1982-06-30
DK228081A (da) 1981-12-06
IE811168L (en) 1981-12-05
FI811685A7 (fi) 1981-12-06

Similar Documents

Publication Publication Date Title
AR228865A1 (es) Procedimientos para aislar antigenos glicoproteicos de virus,del tipo myxovirus,paramyxovirus,rhabdovirus y virus de leucosas,que presentan una membrana lipidica que contiene glicoproteinas
ES535554A0 (es) Procedimiento para preparar una vacuna que comprende un derivado truncado, libre de una membrana de un tipo fijado a una membrana que tiene determinantes antigenicos expuestos.
IT8247706A0 (it) Procedimento per la produzione di virus vaccini
ES491832A0 (es) Un metodo para mantener, replicar y expresar por lo menos una porcion del genoma de un virus n.p.
FI905184A0 (fi) Kimeriska glykoproteiner som innehaoller immunogeniska delar av human parainfluensa-virus typ 3.
AR246985A1 (es) Un procedimiento para preparar dextrosa de alta pureza.
ES501934A0 (es) Un procedimiento para la preparacion de una fibra de alginato.
ES519875A0 (es) Procedimiento para aislar un preparado inmunologicamente activo de glicoproteina gd-1 con envoltura de virus de herpes simplex de tipo 1.
ES2032404T3 (es) Membrana para hemodialisis.
AR241693A1 (es) Montaje de hojas en tandem para una maquina de afeitar
FI823021A7 (fi) Tuotteet, jotka osoittavat hepatitis B virus e antigeenin antigeenisuuden ja menetelmät näiden antigeenien vavalmistamiseksi.
PT84640B (pt) Vector viral que contem um gene que codifica para uma das glicoproteinas (gp) do involucro do virus responsavel pela s.i.d.a. e anticorpos contra essas glicoproteinas
DK47083D0 (da) Fremgangsmade til fremstilling af levende eller inaktiverede vacciner mod infektioes bronkitis
ES529225A0 (es) Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex.
IT1130793B (it) Sistema operativo per separatori centrifughi
ES2148355T3 (es) Procedimiento para la preparacion de nevirapina.
FI902884A7 (fi) Apparatur foer detektering av ett fel i en foerstaerkare som aer foerdubblad med hetberedskapsmetoden.
DK161020C (da) Fremgangsmaade til fremstilling af med en aromatisk gruppe alfa-substituerede alkancarboxylsyrer eller estere deraf samt forbindelser til brug ved fremgangsmaaden
NO823972L (no) Fremgangsmaate for fremstilling av radioaktivt jod-123
ES496461A0 (es) Procedimiento para la separacion de olefinas de gases que contienen olefinas
FI844013L (fi) Foerfarande foer att polymerisera eten och sampolymerisera eten med alfa-olefiner, och katalysatorer, som anvaends i foerfarandet.
IT1129079B (it) Procedimento per la separazione di stillativa di alchilidroperossidi terziari da dialchilperossidi terziari
ES2084596T3 (es) Materiales aislados de felv prototipos para uso en modelos de enfermedades y vacunas.
CY1106077T1 (el) Μεθοδος παρασκευης ξηρου θειοκτικου οξεως
DK115349B (da) Fremgangsmåde til fremstilling af en som vaccine anvendelig, inaktiveret virussuspension, der indeholder et virus, som er isoleret fra in vitro dyrkede nyreceller fra en hundehvalp, der lider af rhinitis eller bronkopneumoni.